研究業績 | 医療関係の方へ | 国立病院機構 熊本医療センター

研究業績

研究業績

  1. Harada M, Takahashi T, Haga Y, Nishikawa T. Comparative study on quick sequential organ failure assessment, systemic inflammatory response syndrome and the shock index in prehospital emergency patients: single-site retrospective study. Acute Medicine & Surgery. 2019;6:131-7.
  2. Nishikawa T, Ono K, Hashimoto S, Kinoshita H, Watanabe T, Araki H, Otsu K, Sakamoto W, Harada M, Toyonaga T, Kawakami S, Fukuda J, Haga Y, Kukidome D, Takahashi T, Araki E. One-hour oral glucose tolerance test plasma glucose at gestational diabetes diagnosis is a common predictor of the need for insulin therapy in pregnancy and postpartum impaired glucose tolerance. Journal of diabetes investigation. 2018;9(6):1370-7.
  3. Kukidome D, Nishikawa T, Sato M, Nishi Y, Shimamura R, Kawashima J, Shimoda S, Mizuta H, Araki E. Impaired balance is related to the progression of diabetic complications in both young and older adults. J Diabetes Complications. 2017;31(8):1275-82.
  4. Kajihara N, Kukidome D, Sada K, Motoshima H, Furukawa N, Matsumura T, Nishikawa T, Araki E. Low glucose induces mitochondrial reactive oxygen species via fatty acid oxidation in bovine aortic endothelial cells. Journal of diabetes investigation. 2017.
  5. Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T. New glycemic targets for patients with diabetes from the Japan Diabetes Society. Journal of diabetes investigation. 2017;8(1):123-5.
  6. Sada K, Nishikawa T, Kukidome D, Yoshinaga T, Kajihara N, Sonoda K, Senokuchi T, Motoshima H, Matsumura T, Araki E. Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1. PloS one. 2016;11(7):e0158619.
  7. Nishikawa T, Araki E. Involvement of advanced glycation end-products in ‘hyperglycemic memory’. Journal of diabetes investigation. 2016;7(3):297-9.
  8. Kukidome D, Nishikawa T, Sato M, Igata M, Kawashima J, Shimoda S, Matsui K, Obayashi K, Ando Y, Araki E. Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy. Diabetic medicine : a journal of the British Diabetic Association. 2016;33(1):62-9.
  9. Igata M, Tsuruzoe K, Kawashima J, Kukidome D, Kondo T, Motoshima H, Shimoda S, Furukawa N, Nishikawa T, Miyamura N, Araki E. Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma. Endocrinology, diabetes & metabolism case reports. 2016;2016:160003.
  10. Hanatani S, Motoshima H, Takaki Y, Kawasaki S, Igata M, Matsumura T, Kondo T, Senokuchi T, Ishii N, Kawashima J, Kukidome D, Shimoda S, Nishikawa T, Araki E. Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice. Journal of clinical biochemistry and nutrition. 2016;59(3):207-14.
  11. Araki E, Haneda M, Kasuga M, Nishikawa T, Kondo T, Ueki K, Kadowaki T. New glycemic targets for patients with diabetes from the Japan Diabetes Society. Diabetology International. 2016;7(4):327–30.
  12. Nishikawa T, Brownlee M, Araki E. Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy. Journal of diabetes investigation. 2015;6(2):137-9.
  13. Fukuda K, Matsumura T, Senokuchi T, Ishii N, Kinoshita H, Yamada S, Murakami S, Nakao S, Motoshima H, Kondo T, Kukidome D, Kawasaki S, Kawada T, Nishikawa T, Araki E. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun. 2015;457(1):23-30.
  14. Takeda Y, Kawashima T, Kiyota K, Oda S, Morimoto N, Kobata H, Isobe H, Honda M, Fujimi S, Onda J, I S, Sakamoto T, Ishikawa M, Nakano H, Sadamitsu D, Kishikawa M, Kinoshita K, Yokoyama T, Harada M, Kitaura M, Ichihara K, Hashimoto H, Tsuji H, Yorifuji T, Nagano O, Katayama H, Ujike Y, Morita K: Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency room. Resuscitation 2014;85:1647–53,.
  15. Takahashi T, Harada M, Kikuno T, Ujihara M, Sadamitsu D, Manabe Y, Yasaka M, Takayama H, Kobori S, Araki E: Prevalence of metabolic syndrome in stroke patients: a prospective multicenter study in Japan. Acute Medicine & Surgery 2014;1:17–22
  16. Pornkuna R, Nishioka C, Takemoto S: What is the role of soluble cytokine receptors in adult T-cell leukemia/lymphoma? Journal of Hematology and Thromboembolic Disease, published online. doi: 10.1111/bjh.13338
  17. Pornkuna R, Wongkhantee S, Jinathongthai S, Shimogawa S, Takemoto S: Effect of blood transfusion on supportive therapy of elderly patients at Kumamoto, Japan as compared with Khon Kaen, Thailand. Journal of Hematology and Thromboembolic Disease 2014;2:152–156
  18. Pornkuna R, Takemoto S: A lack of cellular senescence, formation of microenvironment, and role of soluble CD30 in development of adult T-cell leukemia/lymphoma. Journal of Hematology and Thromboembolic Disease 2014;2:151–156
  19. Pornkuna R, Takemoto S, Hidaka M, Kawano F, Haga Y: Clinical Value of Serum Soluble CD30 Levels in Adult T-Cell Leukemia/Lymphoma. Journal of Hematology and Thromboembolic Disease 2014;2:167–175
  20. Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, Uike N, Saburi Y, Nosaka K, Utsunomiya A, Tobinai K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Moriuchi Y, Imada K, Miyamoto T, Akinaga S, Tomonaga M, Ueda R: Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive ATL: a randomized phase II study. Br J Haematol published online. doi: 10.1111/bjh.13338.
  21. Takemoto S: Serum soluble CD25 and CD30 levels as a biomarker in adult T-cell leukemia/lymphoma patients undergoing allogeneic hematopoietic stem cell transplantation. Journal of Hematology and Thromboembolic Disease 2014;3:182–184
  22. Takemoto S: Human Retroviruses and Soluble CD30 Levels of Patients. Journal of Cell Science & Therapy 2014;5:184–186
  23. Takemoto S, Pornkuna R: Soluble CD30 and peripheral blood or pulmonary involvement of adult T-cell leukemia/lymphoma. Integrative Cancer Science and Therapeutics 2014;1:10–11
  24. Takemoto S, Pornkuna R: Mutualism among HTLV-1-infected different type of cells or among other virus-infected cells. Journal of Hematology and Thromboembolic Disease 2014;2:164–166
  25. Takemoto S, Morimatsu Y, Pornkuna R, Murayama T, Kawano F: CD30+ Cells in Lung of Indolent Type Adult T-Cell Leukemia/Lymphoma and Elevated Serum Levels of Soluble CD30 Associated with Acute Crisis and Relapse of Disease. Journal of Leukemia 2014;2:166–171
  26. Haga Y, Ikejiri K, Wada Y, Ikenaga M, Koike S, Nakamura S, Koseki M: The EPOS-CC score: an integration of independent, tumor- and patient-associated risk factors to predict 5-year overall survival following colorectal cancer surgery. Wolrd J Surg, published online. DOI 10.1007/s00268-015-2962-3
  27. Haga Y, Ikejiri K, Wada Y, Ikenaga M, Takeuchi H: Preliminary study of surgical audit for overall survival following gastric cancer resection. Gastric Cancer 2015;18:138–146
  28. Haga Y, Wada Y, Saitoh T, Takeuchi H, Ikejiri K, Ikenaga M: Value of general surgical risk models for predicting postoperative morbidity and mortality in pancreatic resections for pancreatobiliary carcinomas. J Hepatobiliary Pancreat Sci 2014;21:599–606
  29. Haga Y, Wada Y, Takeuchi H, Furuya T: Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in patients undergoing surgery for choledochocystolithiasis. World J Surg 2014;38:1177–1183
  30. Miyazaki N, Haga Y, Matsukawa H, Ishimura T, Fujita M, Ejima T, Tanimoto H. The development and validation of the Calculation of post-Operative Risk in Emergency Surgery (CORES) model. Surgery Today 2014;44:1443–1456
  31. Piere-Francois SM, Francois B, Takahashi T, et al. Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patienta With Severe Sepsis. JAMA 2013;309:1154–1162
  32. Haga Y, Miyanari N, Takahashi T, Koike S, Kobayashi R, Mizusawa H, Nakamichi C, Goto M. Risk factors for catheter-related bloodstream infections in adult hospitalized patients — Multicenter cohort study. Scand J Infect Dis. 2013;45:773–9
  33. Higashi T, Nakamura F, Haga Y, et al. Quality of Gastric Cancer Care in Designated Cancer Care Hospitals in Japan. Int J Qual Health Care. 2013;25:418–28.
  34. Haga Y, Ikejiri K, Takeuchi H, Ikenaga M, Wada Y: Value of general surgical risk models for predicting postoperative liver failure and mortality following liver surgery. J Surg Oncol. 2012;106:898–904.
  35. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R. Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study. J Clin Oncol. 2012;30:837–842.
  36. Haga Y, Wada Y, Takeuchi H, Ikejiri K, Ikenaga M, Kimura O: Evaluation of modified Estimation of Physiologic Ability and Surgical Stress (mE-PASS) in gastric carcinoma surgery. Gastric Cancer. 2012;15:7–14.
  37. Haga Y, Wada Y, Ikenaga M, Takeuchi H, Ikejiri K: Evaluation of modified Estimation of Physiologic Ability and Surgical Stress (mE-PSS) in colorectal carcinoma surgery. Dis Colon Rectum. 2011;54:1293–1300.
  38. Kotera A, Haga Y, Kei J, Okamoto M, Seo K. Evaluation of Estimation of Physiologic Ability and Surgical Stress to predict in-hospital mortality in cardiac surgery. J Anesth. 2011;25:481–91.
  39. Haga Y, Wada Y, Takeuchi H, Ikejiri K, Ikenaga M: Prediction of anastomotic leak and its prognosis in digestive surgery. World J Surg 2011;35:716–722.
  40. Haga Y, Ikejiri K, Wada Y, Takahashi T, Ikenaga M, Akiyama N, Koike S, Koseki M, Saitoh T: A multicenter prospective study of surgical audit systems. Ann Surg 2011;253:194–201.
  41. Takahashi T, Yamada S, Shimizu C, Kitada M, Sakurai T, Hashimoto S, Harada M. Timing of the appearance of early hypodense computed tomography signs in patients with middle cerebral artery/internal carotid artery embolism. Journal of Japanese Association for Acute Medicine 2010;21:159–164.
  42. Ishikawa Y, Kiyama T, Haga Y, Ishikawa M, Takeuchi H, Kimura O, Harihara Y, Sunouchi K, Furuya T, Kimura M: Maximal sterile barrier precautions do not reduce catheter-related blood stream infections in general surgery units: a multi-institutional randomized controlled trial. Ann Surg, 2010;251:620–623.
  43. Takahashi T, Harada M, Uenohara K, Kikuno T, Honma M, Koizumi M, Uchiyama H, Takahashi T, Ishikura H, Sadamitsu D, Iida H, Miyagatani K, Yamashita H, Saeki S, Takayama H, Kobori S, Kimura A. Efficacy of vasopressin administration in the resuscitation of out-of-hospital cardiopulmonary arrest patients. IRYO 2009;63:380–385.
  44. Haga Y, Odo M, Homma M, Komiyama K, Takeda K, Koike S, Takahashi T, Hiraka K, Yamashita H, Tanakaya K: New prediction rule for mortality in acute mesenteric ischemia. Digestion, 2009;80:104–111.

ページトップへ